{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:48:13Z","timestamp":1772160493510,"version":"3.50.1"},"reference-count":14,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:p>\n                    <jats:bold>Abstract:<\/jats:bold>\n                    Invasive mycoses are pre\u2010eminent causes of morbidity and mortality in the allogeneic stem cell transplant setting. In spite of novel diagnostic modalities, the timely and specific identification of invasive mycoses still remains challenging. We analyzed the case history of 97 consecutive patients receiving 103 allogeneic stem cell transplants between January 2003 and October 2006 performed by a single team at 2 transplant centers in Budapest, Hungary. All patients with febrile neutropenia not responding to broad\u2010spectrum antibacterial therapy received amphotericin B deoxycholate empirically. In cases of proven or probable invasive aspergillosis, intravenous voriconazole was instituted. Patients who failed to improve on initial therapy were treated with an antifungal combination, while responders were switched to oral voriconazole. A total of 38 patients died following allografting. Both centers had an autopsy rate of 100% due to central health care regulations. An infectious cause of death could be identified in 15 cases, invasive fungal disease being the most prevalent and accounting for 10 fatalities. Six patients died of invasive aspergillosis, while invasive candidiasis and mucormycosis led to a fatal outcome in 2 cases each. Despite the regular use of galactomannan antigen detections and imaging, an ante mortem diagnosis of proven\/probable invasive fungal disease could only be established in 4 of 10 autopsy\u2010verified cases (aspergillosis: 3, candidiasis: 1, mucormycosis: 0). In the remaining 6 patients, deep mycoses were missed clinically and were revealed only by postmortem histology. Present diagnostic and therapeutic strategies still seem to be suboptimal for the management of invasive fungal diseases in the high\u2010risk allogeneic stem cell transplant population.\n                  <\/jats:p>","DOI":"10.1111\/j.1399-3062.2007.00264.x","type":"journal-article","created":{"date-parts":[[2007,7,2]],"date-time":"2007-07-02T01:07:08Z","timestamp":1183338428000},"page":"106-109","source":"Crossref","is-referenced-by-count":47,"title":["Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy\u2010driven survey"],"prefix":"10.1111","volume":"10","author":[{"given":"J.","family":"Sink\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Csomor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Nikolova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lueff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kriv\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rem\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1.","family":"B\u00e1tai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Masszi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,7]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/339202"},{"key":"e_1_2_6_3_2","first-page":"955","article-title":"Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation","volume":"42","author":"Cordonnier C","year":"2006","journal-title":"a 1-year retrospective study of consecutive patients at French transplantation centers"},{"key":"e_1_2_6_4_2","first-page":"358","article-title":"Aspergillosis case fatality rate","volume":"32","author":"Lin S\u2010J","year":"2001","journal-title":"systematic review of the literature"},{"key":"e_1_2_6_5_2","first-page":"1242","article-title":"Galactomannan and computed tomography\u2010based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection","volume":"41","author":"Maertens J","year":"2005","journal-title":"a prospective feasibility study"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.2002.t01-2-02002.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/423381"},{"key":"e_1_2_6_8_2","first-page":"7","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants","volume":"34","author":"Ascioglu S","year":"2002","journal-title":"an international consensus"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.3.1385"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20358"},{"key":"e_1_2_6_11_2","first-page":"675","article-title":"Autopsy\u2010identified infections among bone marrow transplant recipients","volume":"16","author":"Chandrasekar PH","year":"1995","journal-title":"a clinico-pathologic study of 56 patients. Bone Marrow Transplantation Team"},{"key":"e_1_2_6_12_2","first-page":"986","article-title":"Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center","volume":"91","author":"Chamilos G","year":"2006","journal-title":"an autopsy study over a 15-year period (1989\u20132003)"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.35.540"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/313803"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-005-0078-7"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2007.00264.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3062.2007.00264.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T12:20:16Z","timestamp":1696854016000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2007.00264.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1111\/j.1399-3062.2007.00264.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2007.00264.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718535016.793498825","asserted-by":"object"}]},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}